- Investing Ideas
- /
- Japanese Biotech Breakthroughs
Japanese Biotech Breakthroughs
Results
3
0 new
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
3 companies
Solasia Pharma K.K
Market Cap: JP¥7.2b
Engages in the development and marketing of oncology drugs in Japan and other Asian countries.
4597
JP¥31.00
7D
-18.4%
1Y
6.9%
Japan Tissue Engineering
Market Cap: JP¥17.6b
Engages in the regenerative medicine business in Japan.
7774
JP¥419.00
7D
-10.7%
1Y
-42.2%
Takara Bio
Market Cap: JP¥95.9b
Engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally.
4974
JP¥779.00
7D
-7.8%
1Y
-18.9%
Page 1 of 1